Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,131 | 51,230 | 63,902 | 65,675 | 16,577 |
| Marketable Securities | 299,518 | 284,006 | 244,828 | 157,994 | 193,507 |
| Receivables | 36,533 | 51,313 | 67,205 | 10,614 | 12,841 |
| TOTAL | $436,837 | $401,848 | $380,389 | $237,819 | $232,156 |
| Non-Current Assets | |||||
| PPE Net | 8,596 | 10,927 | 8,374 | 8,049 | 8,004 |
| Investments And Advances | 32,634 | 65,013 | 16,389 | 70,038 | 32,119 |
| Other Non-Current Assets | 8,065 | 12,041 | 9,075 | 10,731 | 8,998 |
| TOTAL | $49,295 | $87,981 | $33,838 | $88,818 | $49,121 |
| Total Assets | $486,132 | $489,829 | $414,227 | $326,637 | $281,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,737 | 6,689 | 4,745 | 3,714 | 3,377 |
| Accrued Expenses | 14,159 | 15,920 | 9,892 | 7,970 | 4,512 |
| TOTAL | $24,157 | $22,609 | $16,025 | $20,982 | $7,889 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,395 | 4,728 | 4,523 | 3,979 | 3,452 |
| TOTAL | $6,395 | $4,728 | $4,523 | $3,979 | $3,452 |
| Total Liabilities | $30,552 | $27,337 | $20,548 | $24,961 | $11,341 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,079 | 19,726 | 19,424 | 19,126 | 19,039 |
| Common Shares | 201 | 197 | 194 | 191 | 190 |
| Retained earnings | 127,572 | 163,740 | 117,357 | 45,356 | 27,646 |
| Other shareholders' equity | 844 | 146 | -398 | -112 | 19 |
| TOTAL | $455,580 | $462,492 | $393,679 | $301,676 | $269,936 |
| Total Liabilities And Equity | $486,132 | $489,829 | $414,227 | $326,637 | $281,277 |